Business Context and Reporting Period
Company: InMed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 18, 2023
Reporting Period: Single event date (March 18, 2023)
Business Context: The filing serves as a Regulation FD disclosure to announce a scheduled investor relations event.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a future corporate communication event.
Guidance, Outlook, and Management Commentary
- Event Announcement: Eric A. Adams, President & CEO, will participate in the Water Tower Research Fireside Chat Series.
- Event Date: May 23, 2023.
- Event Time: 1:00 pm ET.
- Legal Status: The information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the Water Tower Research Fireside Chat (May 23, 2023, 1:00 pm ET).
- Confirm the participation of Eric A. Adams as the CEO.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.